https://www.prnewswire.com/news-releases/lipocine-announces-positive-lpcn-1144-nash-open-label-extension-study-results-301545697.html
LPCN 1144 was well tolerated over 72-week exposure with no observed safety signals
Liver injury markers were reduced and maintained with extended LPCN 1144...